Koers Dawnrays Pharmaceutical (Holdings) Limited
Aandelen
2348
KYG2687M1006
Farmaceutische producten
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,17 HKD | 0,00% | +1,74% | +11,43% |
Omzet 2022 | 1,28 mld. 176 mln. 1,38 mld. 164 mln. | Omzet 2023 | 1,15 mld. 159 mln. 1,24 mld. 148 mln. | Marktkapitalisatie | 1,43 mld. 198 mln. 1,55 mld. 184 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 358 mln. 49,41 mln. 387 mln. 46,07 mln. | Nettowinst (verlies) 2023 | 326 mln. 44,99 mln. 352 mln. 41,96 mln. | EV/omzet 2022 | 0,54 x |
Nettoliquiditeiten 2022 | 1,07 mld. 148 mln. 1,16 mld. 138 mln. | Nettoliquiditeiten 2023 | 1,05 mld. 145 mln. 1,14 mld. 136 mln. | EV/omzet 2023 | 0,33 x |
K/w-verhouding 2022 |
4,93
x | K/w-verhouding 2023 |
4,4
x | Werknemers | 1.143 |
Dividendrendement 2022 |
6,63% | Dividendrendement 2023 |
7,61% | Vrij verhandelbaar | 39,97% |
1 week | +1,74% | ||
3 maanden | +7,34% | ||
6 maanden | +11,43% | ||
Lopend jaar | +11,43% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wei Xian Wu
CEO | Chief Executive Officer | 55 | 16-02-22 |
Yi jun Wu
DFI | Director of Finance/CFO | 59 | 01-12-02 |
Kei Ling Li
CHM | Chairman | 75 | 01-10-02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kei Ling Li
CHM | Chairman | 75 | 01-10-02 |
Yung Lai Hung
BRD | Director/Board Member | 79 | 01-10-02 |
Hong Man Leung
BRD | Director/Board Member | 49 | 01-11-05 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,17 | 0,00% | 40 000 |
25-04-24 | 1,17 | 0,00% | 0 |
24-04-24 | 1,17 | -1,68% | 144 000 |
23-04-24 | 1,19 | +2,59% | 112 000 |
22-04-24 | 1,16 | +0,87% | 12 000 |
uitgestelde koers Hong Kong S.E., 26 april 2024 om 08:10 uur
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+11,43% | 224 mln. | |
+24,17% | 556 mld. | |
-6,33% | 354 mld. | |
+19,90% | 331 mld. | |
+7,95% | 296 mld. | |
+13,45% | 233 mld. | |
+6,04% | 201 mld. | |
-10,51% | 193 mld. | |
-12,26% | 143 mld. | |
-6,47% | 144 mld. |